InvestorsHub Logo
Followers 68
Posts 823
Boards Moderated 0
Alias Born 03/19/2009

Re: None

Thursday, 08/29/2013 3:30:35 AM

Thursday, August 29, 2013 3:30:35 AM

Post# of 10802
TEEE(.09)...2-part reverse merger.....

5.85M shares outstanding
$526K market cap
A 1:14.62 reverse split is expected in the next week or so.

Picked up a few more shares of the TEEE shell. All significant debt/liabilities appear to have been resolved now, with conversions into common stock generally in the 4-7 cent area (including shares issued to the shell's CEO, who will remain a Director with the new company).

The valuation of the shell under the 10-cent area still seems reasonable to me prior to the entry into a RM deal. Although there is quite a bit of risk involved here since I don't know what the financials and balance sheet of the RM target(s) look like, or what the final share structure will look like, I think there is a chance this stock might become an interesting low float and/or momentum play at some point after the reverse merger. Following the reverse split and the first part of the RM transaction, it appears that the tradeable float on this stock could be as low as 250K for awhile.

RM part one: 1:14.62 reverse split, name change to "Fuse Medical", and issue 3.6M shares to acquire PharmHouse Pharmacy. Total shares outstanding will be 4M.

Craig Longhurst, owner of PharmHouse Pharmacy, will control 2.9M shares of the company at that point.

RM part two: acquisition of Fuse Medical, LLC.

Details of that proposed transaction have not be disclosed yet, but according to the filings (SC 14F1) Craig Longhurst is expected to distribute some of his shares as part of the deal......

Mr. Longhurst has agreed to distribute a portion of the shares issued to him in connection with a proposed acquisition of Fuse Medical, LLC.



http://www.fusemedical.com/



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.